GIS
22
-4
KSS
39
-7
LH
40
-5
XYL
35
-2
VRSN
53
-5
WDC
37
-3
VRTX
47
-6
JNPR
50
-6
CVX
43
-3
BDX
56
10
PBI
56
-2
EOG
56
-2
DAL
84
-3
NAVI
52
-2
PAYX
48
-6
MAR
63
-5
ICE
59
-3
K
51
-3
NEM
40
3
REGN
38
-2
GIS
22
-4
KSS
39
-7
LH
40
-5
XYL
35
-2
VRSN
53
-5
WDC
37
-3
VRTX
47
-6
JNPR
50
-6
CVX
43
-3
BDX
56
10
PBI
56
-2
EOG
56
-2
DAL
84
-3
NAVI
52
-2
PAYX
48
-6
MAR
63
-5
ICE
59
-3
K
51
-3
NEM
40
3
REGN
38
-2
Financhill
Back

Vanguard Materials ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
36

VAW
Vanguard Materials ETF

Last Price:
204.25
Seasonality Move:
2.91%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
36
Vanguard Materials ETF (VAW) is a Sell

Is Vanguard Materials ETF a Buy, Sell or Hold?

  • The current Vanguard Materials ETF [VAW] share price is $204.10. The Score for VAW is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • VAW is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VAW Stock Price Chart

What is Vanguard Materials ETF's stock price today?

  • The Vanguard Materials ETF share price today is $204.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VAW is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

VAW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.62 Sell
Relative Strength Index (14 RSI): 38.39 Sell
Chaikin Money Flow: -21722 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (206.64 - 212.8) Sell
Bollinger Bands (100): (196.36 - 209.82) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

VAW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 208.79 Sell
20-day SMA: 208.73 Sell
50-day SMA: 208.34 Sell
200-day SMA: 199.82 Buy
8-day EMA: 207.24 Sell
20-day EMA: 208.4 Sell
50-day EMA: 207.45 Sell
200-day EMA: 199.38 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Vanguard Materials ETF Earnings Growth & VAW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Vanguard Materials ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):